Characterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental design

The recent introduction of advanced magnetic resonance (MR) imaging techniques to characterize focal and global degeneration in multiple sclerosis (MS), like the Composite Hindered and Restricted Model of Diffusion, or CHARMED, diffusional kurtosis imaging (DKI) and Neurite Orientation Dispersion an...

Full description

Bibliographic Details
Main Authors: De Santis, S, Bastiani, M, Droby, A, Kolber, P, Zipp, F, Pracht, E, Stoecker, T, Groppa, S, Roebroeck, A
Format: Journal article
Language:English
Published: Elsevier 2018
_version_ 1826256718367031296
author De Santis, S
Bastiani, M
Droby, A
Kolber, P
Zipp, F
Pracht, E
Stoecker, T
Groppa, S
Roebroeck, A
author_facet De Santis, S
Bastiani, M
Droby, A
Kolber, P
Zipp, F
Pracht, E
Stoecker, T
Groppa, S
Roebroeck, A
author_sort De Santis, S
collection OXFORD
description The recent introduction of advanced magnetic resonance (MR) imaging techniques to characterize focal and global degeneration in multiple sclerosis (MS), like the Composite Hindered and Restricted Model of Diffusion, or CHARMED, diffusional kurtosis imaging (DKI) and Neurite Orientation Dispersion and Density Imaging (NODDI) made available new tools to image axonal pathology non-invasively in vivo. These methods already showed greater sensitivity and specificity compared to conventional diffusion tensor-based metrics (e.g., fractional anisotropy), overcoming some of its limitations. While previous studies uncovered global and focal axonal degeneration in MS patients compared to healthy controls, here our aim is to investigate and compare different diffusion MRI acquisition protocols in their ability to highlight microstructural differences between MS and control tissue over several much used models. For comparison, we contrasted the ability of fractional anisotropy measurements to uncover differences between lesion, normal-appearing white matter (WM), gray matter and healthy tissue under the same imaging protocols. We show that: (1) focal and diffuse differences in several microstructural parameters are observed under clinical settings; (2) advanced models (CHARMED, DKI and NODDI) have increased specificity and sensitivity to neurodegeneration when compared to fractional anisotropy measurements; and (3) both high (3 T) and ultra-high fields (7 T) are viable options for imaging tissue change in MS lesions and normal appearing WM, while higher b-values are less beneficial under the tested short-time (10 min acquisition) conditions.
first_indexed 2024-03-06T18:06:42Z
format Journal article
id oxford-uuid:01ac31c0-6fdb-42bc-a518-8244451fd707
institution University of Oxford
language English
last_indexed 2024-03-06T18:06:42Z
publishDate 2018
publisher Elsevier
record_format dspace
spelling oxford-uuid:01ac31c0-6fdb-42bc-a518-8244451fd7072022-03-26T08:36:17ZCharacterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental designJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:01ac31c0-6fdb-42bc-a518-8244451fd707EnglishSymplectic Elements at OxfordElsevier2018De Santis, SBastiani, MDroby, AKolber, PZipp, FPracht, EStoecker, TGroppa, SRoebroeck, AThe recent introduction of advanced magnetic resonance (MR) imaging techniques to characterize focal and global degeneration in multiple sclerosis (MS), like the Composite Hindered and Restricted Model of Diffusion, or CHARMED, diffusional kurtosis imaging (DKI) and Neurite Orientation Dispersion and Density Imaging (NODDI) made available new tools to image axonal pathology non-invasively in vivo. These methods already showed greater sensitivity and specificity compared to conventional diffusion tensor-based metrics (e.g., fractional anisotropy), overcoming some of its limitations. While previous studies uncovered global and focal axonal degeneration in MS patients compared to healthy controls, here our aim is to investigate and compare different diffusion MRI acquisition protocols in their ability to highlight microstructural differences between MS and control tissue over several much used models. For comparison, we contrasted the ability of fractional anisotropy measurements to uncover differences between lesion, normal-appearing white matter (WM), gray matter and healthy tissue under the same imaging protocols. We show that: (1) focal and diffuse differences in several microstructural parameters are observed under clinical settings; (2) advanced models (CHARMED, DKI and NODDI) have increased specificity and sensitivity to neurodegeneration when compared to fractional anisotropy measurements; and (3) both high (3 T) and ultra-high fields (7 T) are viable options for imaging tissue change in MS lesions and normal appearing WM, while higher b-values are less beneficial under the tested short-time (10 min acquisition) conditions.
spellingShingle De Santis, S
Bastiani, M
Droby, A
Kolber, P
Zipp, F
Pracht, E
Stoecker, T
Groppa, S
Roebroeck, A
Characterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental design
title Characterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental design
title_full Characterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental design
title_fullStr Characterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental design
title_full_unstemmed Characterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental design
title_short Characterizing microstructural tissue properties in Multiple Sclerosis with diffusion MRI at 7 T and 3 T: The impact of the experimental design
title_sort characterizing microstructural tissue properties in multiple sclerosis with diffusion mri at 7 t and 3 t the impact of the experimental design
work_keys_str_mv AT desantiss characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign
AT bastianim characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign
AT drobya characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign
AT kolberp characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign
AT zippf characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign
AT prachte characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign
AT stoeckert characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign
AT groppas characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign
AT roebroecka characterizingmicrostructuraltissuepropertiesinmultiplesclerosiswithdiffusionmriat7tand3ttheimpactoftheexperimentaldesign